We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USB icon
1376
US Bancorp
USB
$99.6B
– –
-6,878
Closed -$290K
UTI icon
1377
Universal Technical Institute
UTI
$1.59B
– –
-77,973
Closed -$2M
UWMC icon
1378
UWM Holdings
UWMC
$434M
– –
-16,066
Closed -$87.7K
VAC icon
1379
Marriott Vacations Worldwide
VAC
$4.25B
– –
-4,794
Closed -$308K
VAL icon
1380
Valaris
VAL
$5.47B
– –
-12,157
Closed -$477K
VET icon
1381
Vermilion Energy
VET
$1.66B
– –
-10,121
Closed -$82K
VICI icon
1382
CALL
VICI Properties
VICI
$29.4B
– –
-40,600
Closed -$1.32M
VKTX icon
1383
Viking Therapeutics
VKTX
$4B
– –
-52,467
Closed -$1.27M
VMI icon
1384
Valmont Industries
VMI
$9.53B
– –
-1,107
Closed -$316K
VNDA icon
1385
Vanda Pharmaceuticals
VNDA
$302M
– –
-24,708
Closed -$113K
VRA icon
1386
Vera Bradley
VRA
$98.7M
– –
-13,243
Closed -$29.8K
VRNS icon
1387
Varonis Systems
VRNS
$5B
– –
-9,073
Closed -$367K
VRP icon
1388
Invesco Variable Rate Preferred ETF
VRP
$3.01B
– –
-25,000
Closed -$606K
VRTX icon
1389
Vertex Pharmaceuticals
VRTX
$126B
– –
-5,632
Closed -$2.73M
VSEC icon
1390
VSE Corp
VSEC
$6.12B
– –
-1,871
Closed -$225K
VTRS icon
1391
Viatris
VTRS
$18.9B
– –
-296,144
Closed -$2.58M
VUZI icon
1392
Vuzix
VUZI
$224M
– –
-10,526
Closed -$21.5K
VYGR icon
1393
Voyager Therapeutics
VYGR
$201M
– –
-25,817
Closed -$87.3K
WBA
1394
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-126,400
Closed -$1.41M
WDAY icon
1395
PUT
Workday
WDAY
$44.4B
– –
-1,400
Closed -$327K
WEAV icon
1396
Weave Communications
WEAV
$423M
– –
-15,263
Closed -$169K
WELL icon
1397
Welltower
WELL
$171B
– –
-9,715
Closed -$1.49M
WELL icon
1398
PUT
Welltower
WELL
$171B
– –
-3,800
Closed -$582K
WEN icon
1399
Wendy's
WEN
$1.46B
– –
-10,155
Closed -$149K
WFC icon
1400
Wells Fargo
WFC
$264B
– –
-7,554
Closed -$542K
54 55
56
57 58

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.